Question · asked by 1 review
Oral vs vaginal administration of oestradiol and dydrogesterone: Adverse events
- Population
- women with premature ovarian insufficiency (POI) awaiting oocyte donation
- Intervention
- Oral
- Comparison
- vaginal administration of oestradiol and dydrogesterone
- Outcome
- Adverse events
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Oral vs vaginal administration of oestradiol and dydrogesterone Adverse events · women with premature ovarian insufficiency (POI) awaiting oocyte donation The review found no eligible studies for this question. Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency (2022) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Oral vs intramuscular vitamin B12 · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.